BRUNETTO, MAURIZIA ROSSANA Statistiche

BRUNETTO, MAURIZIA ROSSANA  

DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE  

Mostra records
Risultati 1 - 20 di 432 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autore(i) File
2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference. 1-gen-2019 Cornberg, M; Lok, As; Terrault, Na; Zoulim, F; Berg, T; Brunetto, Mr; Buchholz, S; Buti, M; Chan, Hl; Chang, Km; Dandri, M; Dusheiko, G; Feld, Jj; Ferrari, C; Ghany, M; Janssen, Hla; Kennedy, P; Lampertico, P; Liang, J; Locarnini, S; Maini, Mk; Mishra, P; Papatheodoridis, G; Petersen, J; Schlottmann, S; Wang, S; Wedemeyer, H.
2019 EASL-AASLD HBV Treatment Endpoints Conference Faculty. Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference. 1-gen-2019 Berg, T; Brunetto, Mr; Buchholz, S; Buti, M; Chan, Hly; Chang, Km; Dandri, M; Dusheiko, G; Feld, Jj; Ferrari, C; Ghany, M; Janssen, Hla; Kennedy, P; Lampertico, P; Liang, J; Locarnini, S; Maini, Mk; Mishra, P; Papatheodoridis, G; Petersen, J; Schlottmann, S; Wang, S; Wedemeyer, H; Afdhal, Nh; Apelian, D; Brown, N; Beumont-Mauviel, M; Cloherty, G; Cornberg, M; Dickens, T; Donaldson, E; Gaggar, A; Given, B; Lopatin, U; Lok, A; Miller, V; Mishra, P; Picchio, G; Revill, P; Schlottmann, S; Terrault, N; Vaillant, A; Vernoux, L; Wang, S; Wat, C; Young, J; Zoulim, F.
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection 1-gen-2018 Agarwal, Kosh; Brunetto, Maurizia; Seto, Wai Kay; Lim, Young-Suk; Fung, Scott; Marcellin, Patrick; Ahn, Sang Hoon; Izumi, Namiki; Chuang, Wan–long; Bae, Ho; Sharma, Manoj; Janssen, Harry L. A.; Pan, Calvin Q.; Çelen, Mustafa Kemal; Furusyo, Norihiro; Shalimar, Dr; Yoon, Ki Tae; Trinh, Huy; Flaherty, John F.; Gaggar, Anuj; Lau, Audrey H.; Cathcart, Andrea L.; Lin, Lanjia; Bhardwaj, Neeru; Suri, Vithika; Mani Subramanian, G.; Gane, Edward J.; Buti, Maria; Chan, Henry L. Y.
A dynamic analysis of IgM anti-HCV helps to distinguish hepatitis C from acute rejection in liver transplant patients 1-gen-2001 Brunetto, MAURIZIA ROSSANA; Ciccorossi, P; Filipponi, Franco; Giannotti, Alessia; Oliveri, F; Coco, B; Bonino, Ferruccio; Campa, Mario; Mosca, Franco
A multiphase model of th dynamics of HBV infection in HBeAg-negative patients during pegylated interferon-alfa2a, lamivudine and combination therapy 1-gen-2006 Colombatto, P; Civitano, L; Bizzarri, R; Oliveri, F; Choudhury, S; Gieschke, R; Bonino, Ferruccio; Brunetto, MAURIZIA ROSSANA
A multiphase model of the dynamics of HBV infection in BBeAg-negative patients during pegylated interferon-alpha 2a, lamivudine and combination therapy 1-gen-2006 Colombatto, P; Civitano, L; Bizzarri, R; Oliveri, F; Choudhury, S; Gieschke, R; Bonino, F; Brunetto, Mr
A new bio-mathematical model to describe the dynamics of HBV-DNA and infected hepatocytes in HBEAG-negative/anti-HBE-positive chronic hepatitis B patients treated with peginterferon alfa-2a (40kd) (PEGASYS (R)), lamivudine, or PEGASYS (R) plus lamivudine combin 1-gen-2004 Colombatto, P; Bizzarri, R; Civitano, L; Oliveri, F; Bonino, F; Germanidis, G; Farci, P; Kitis, G; Hadziyannis, S; Choudhury, S; Gieschke, R; Zahm, F; Brunetto, M
A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B 1-gen-1990 Brunetto, MAURIZIA ROSSANA; Stemler, M; Bonino, Ferruccio; Schodel, F; Oliveri, F; Rizzetto, M; Verme, G; Will, H.
A new hepatitis C virus-like flavivirus in patients with cryptogenic liver disease associated with elevated GGT and alkaline phosphatise serum levels 1-gen-1997 Colombatto, P; Randone, A; Civitico, G; MONTI GORIN, G; Dolci, L; Medaina, N; Calleri, G; Oliveri, F; Baldi, M; Tappero, G; Volpes, R; David, E; Verme, G; Smedile, A; Bonino, Ferruccio; Brunetto, MAURIZIA ROSSANA
A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers 1-gen-2008 Mazzoni, A; Colombatto, P; Bindi, L; Biancofiore, GIANDOMENICO LUIGI; Tascini, C; Menichetti, F; Brunetto, MAURIZIA ROSSANA; Scatena, F; Filipponi, Franco
A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease 1-gen-1990 Ulrich, Pp; Bhat, Ra; Kelly, I; Brunetto, MAURIZIA ROSSANA; Bonino, Ferruccio; Vyas, Gn
Active HBV replication in HBsAg carriers with chronic Delta infection 1-gen-1985 Bonino, Ferruccio; Negro, F; Chiaberge, E; Brunetto, MAURIZIA ROSSANA; Verme, G; Rizzetto, M.
Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy 1-gen-2004 Marocci, C; Pinchera, A; Bartalena, L; Brunetto, Mr; Morabito, Evangelia; Marinó, M.
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D. 1-gen-2018 Lampertico, P; Brunetto, Mr; Craxì, A; Gaeta, Gb; Rizzetto, M; Rozzi, A; Colombo, M; HERMES Study, Group.
Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects 1-gen-1996 TORRANI CERENZIA, M; Fiume, L; DE BERNARDI VENON, W; Lavezzo, B; Brunetto, MAURIZIA ROSSANA; Ponzetto, A; DI STEFANO, G; Busi, C; Mattioli, A; Gervasi, Gb; Bonino, Ferruccio; Verme, G.
Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects 1-gen-1996 Verme, G; Bonino, F; Gervasi, Gb; Mattioli, A; Busi, C; Di Stefano, G; Ponzetto, A; Brunetto, Mr; Lavezzo, B; De Bernardi Venon, W; Fiume, L; Torrani Cerenzia, M.
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy 1-gen-2015 Sisti, Eleonora; Coco, Barbara; Menconi, Francesca; Leo, Marenza; Rocchi, Roberto; Latrofa, Francesco; Profilo, MARIA ANTONIETTA; Mazzi, Barbara; Vitti, Paolo; Marcocci, Claudio; Brunetto, MAURIZIA ROSSANA; Marino', Michele
AISF position paper on HCV in immunocompromised patients. 1-gen-2019 Marzano, A; Angelucci, E; Astegiano, M; Baratelli, C; Biancone, L; Bironzo, P; Brancaccio, G; Brunetto, Mr; Bruno, R; Burra, P; Cabras, Mg; Caraceni, P; Chialà, ; Clemente, Mg; Colli, A; Daniele, B; De Gasperi, E; Di Marco, V; Ditto MCFagiuoli, S; Ferri, C; Gaeta, Gb; Grossi, Pa; Imperatrice, B; Lampertico, P; Macaluso, Fs; Madonia, S; Marignani, M; Mazzarelli, C; Mella, A; Missale, G; Parisi, S; Pasulo, L; Puoti, M; Rendina, M; Ribaldone, D; Rossi, G; Toniutto, P; Tucci, A; Vajro, P; Viganò, M; Volpes, R; Zignego, Al.
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 1-gen-2016 Alisi, A; Balsano, C; Bernabucci, V; Berzigotti, A; Brunetto, MAURIZIA ROSSANA; Bugianesi, E; Burra, P; Calvaruso, V; Cariani, E; Coco, B; Colle, I; Critelli, R; De Martin, E; Del Buono, M; Fabregat, I; Faillaci, F; Fattovich, G; Floreani, A; Garcia Tsao, G; Housset, C; Karampatou, A; Lei, B; Mangia, A; Martinez Chantar, Ml; Milosa, F; Morisco, F; Nasta, P; Ozben, T; Pollicino, T; Ponti, Ml; Pontisso, P; Reeves, H; Rendina, M; Rodríguez Castro, Ki; Sagnelli, C; Sebastiani, G; Smedile, A; Taliani, G; Vandelli, C; Vanni, E; Villa, E; Vukotic, R; Zignego, Al; Burra, P; Rodríguez Castro, K; Guarino, M; Morisco, F; Villa, E; Mazzella, G.
Alpha-fetoprotein in hepatic pathology and hepatocarcinoma 1-gen-1989 Gindro, T; Brunetto, Mr; Arrigoni, A; Piantino, P